NYSE - Delayed Quote USD

ResMed Inc. (RMD)

218.57 -1.40 (-0.64%)
At close: May 17 at 4:00 PM EDT
219.80 +1.23 (+0.56%)
After hours: May 17 at 6:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
4,584,159.00
4,222,993.00
3,578,127.00
3,196,825.00
2,957,013.00
Cost of Revenue
2,026,996.00
1,867,331.00
1,553,816.00
1,357,725.00
1,239,227.00
Gross Profit
2,557,163.00
2,355,662.00
2,024,311.00
1,839,100.00
1,717,786.00
Operating Expense
1,268,020.00
1,203,665.00
1,022,161.00
926,749.00
908,727.00
Operating Income
1,289,143.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
Net Non Operating Interest Income Expense
-54,730.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
Other Income Expense
-50,545.00
-2,954.00
-19,355.00
-5,062.00
-36,615.00
Pretax Income
1,183,868.00
1,101,664.00
960,483.00
883,662.00
733,088.00
Tax Provision
225,489.00
204,108.00
181,046.00
409,157.00
111,414.00
Net Income Common Stockholders
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
Diluted NI Available to Com Stockholders
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
Basic EPS
6.53
6.12
5.34
3.27
4.31
Diluted EPS
6.50
6.09
5.30
3.24
4.27
Basic Average Shares
147,046.25
146,765.00
146,066.00
145,313.00
144,338.00
Diluted Average Shares
147,566.75
147,455.00
147,043.00
146,451.00
145,652.00
Total Operating Income as Reported
1,213,946.00
1,131,871.00
1,000,286.00
903,678.00
809,659.00
Total Expenses
3,295,016.00
3,070,996.00
2,575,977.00
2,284,474.00
2,147,954.00
Net Income from Continuing & Discontinued Operation
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
Normalized Income
1,002,878.97
897,473.69
780,950.57
480,836.29
621,165.19
Interest Income
--
--
--
362.00
1,021.00
Interest Expense
--
--
--
23,989.00
40,377.00
Net Interest Income
-54,730.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
EBIT
1,289,143.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
EBITDA
1,505,796.00
1,349,559.00
1,195,991.00
1,103,869.00
990,432.00
Reconciled Cost of Revenue
1,857,921.00
1,711,789.00
1,391,053.00
1,197,285.00
1,087,946.00
Reconciled Depreciation
216,653.00
197,562.00
193,841.00
191,518.00
181,373.00
Net Income from Continuing Operation Net Minority Interest
958,379.00
897,556.00
779,437.00
474,505.00
621,674.00
Total Unusual Items Excluding Goodwill
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
Total Unusual Items
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
Normalized EBITDA
1,560,766.00
1,349,458.00
1,197,855.00
1,112,542.00
989,832.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-10,470.03
18.69
-350.43
-2,341.71
91.19
6/30/2020 - 6/2/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WST West Pharmaceutical Services, Inc.
355.64
+0.43%
 
ALC Alcon Inc.
88.83
-0.26%
 
BDX Becton, Dickinson and Company
236.30
-0.14%
 
TFX Teleflex Incorporated
217.64
-0.43%
 
COO The Cooper Companies, Inc.
97.31
-0.60%
 
BAX Baxter International Inc.
35.25
+0.23%
 
ISRG Intuitive Surgical, Inc.
398.82
+0.60%
 
HAE Haemonetics Corporation
95.73
+0.98%
 
RGEN Repligen Corporation
171.94
+0.53%
 
ICUI ICU Medical, Inc.
103.99
-2.15%